Table 1.
Characteristica | Survival (n = 106) | In-hospital Mortality (n = 27) | P Value |
---|---|---|---|
Age, y | 58 (48–67) | 61 (46–76) | .639b |
Male, No. (%) | 60 (56.6) | 14 (51.9) | .659c |
Comorbid conditions, No. (%) | |||
Dialysis | 19 (17.9) | 6 (22.2) | .610c |
Cardiovascular disease | 34 (32.1) | 9 (33.3) | .901c |
Diabetes | 43 (40.6) | 10 (37.0) | .845c |
Immunosuppression | 30 (28.3) | 6 (22.2) | .526c |
White blood cells, 103/μL | 11.8 (7.7–15.3) | 14.5 (8.9–19.9) | .084b |
Pitt bacteremia score | 0 (0–3) | 2 (1–5) | <.001b |
Source of bacteremia | |||
Primary endovasculard, No. (%) | 22 (20.7) | 14 (51.8) | .003c |
Secondarye, No. (%) | 60 (56.6) | 10 (37.0) | .085c |
Catheter-associated, No. (%) | 24 (22.6) | 3 (11.1) | .283c |
Infection onset | |||
Community | 75 | 21 | .631c |
Hospital | 31 | 6 | |
Persistent bacteremia ≥4 d, No. (%) | 32 (30.2) | 15 (55.5) | .014c |
Hospital length of stay, d | 8 (6–15) | 8 (5–12) | .531b |
aAll characteristics data are presented as median (interquartile range) unless otherwise noted.
bMann-Whitney U test.
cPearson test.
dIncludes endovascular, endocarditis, or unknown presumed to be endovascular source.
eIncludes any site secondary to another primary nonendovascular focus of infection.